Clinical Evaluation of MyoCare in Europe (CEME)

NAUnknownINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

September 15, 2022

Primary Completion Date

June 30, 2025

Study Completion Date

July 31, 2025

Conditions
Myopia, Progressive
Interventions
DEVICE

MyoCare

Children assigned to the study group will wear ZEISS MyoCare lenses, while those assigned to the control group will wear conventional ZEISS ClearView single-vision lenses in their spectacles. Both lenses will be made of the same material (MR8) and hard as well as anti-reflection coating (ZEISS DuraVision Platinum) and will have the same surface treatments.

DEVICE

ClearView

Children assigned to the study group will wear ZEISS MyoCare lenses, while those assigned to the control group will wear conventional ZEISS ClearView single-vision lenses in their spectacles. Both lenses will be made of the same material (MR8) and hard as well as anti-reflection coating (ZEISS DuraVision Platinum) and will have the same surface treatments.

Trial Locations (1)

28037

Universidad Complutense de Madrid, Madrid

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Cooperativa de Ensino Superior, Politécnico e Universitário

OTHER

collaborator

Novovision

UNKNOWN

collaborator

Instituto de Cirugia Ocular

OTHER

collaborator

Miranza Virgen de Lujan

UNKNOWN

collaborator

ICQO Instituto Quirúrgico de Oftalmología

UNKNOWN

collaborator

CPO Clinica Privada de Oftalmologia, S.A.

UNKNOWN

collaborator

Carl Zeiss Vision International GmbH

UNKNOWN

lead

Universidad Complutense de Madrid

OTHER